Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: PCSK9 inhibitors from Day 1

2 September 2024 (15:30 - 15:45)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Shamir R Mehta

McMaster University, Hamilton (Canada)

3 More presentations in this session

Presentation thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: combination therapy from Day 1

Doctor M. Lettino (Monza, IT)

Presentation thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: together with anti-inflammatory therapy from Day 1

Professor M. Sabatine (Boston, US)

Presentation thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients - discussion

Access the full session

Session thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients

The Event

Event poster

ESC Congress 2024

2 September 2024 15:30 CET

You may be interested in

Congress Presentation

What is the benefit of starting earlier?

Congress Session

PCSK9 inhibitors for acute coronary syndromes: the era of early implementation

Congress Session

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources